VERTEX GENETIC THERAPIES Trademark
Trademark Overview
On Tuesday, September 10, 2019, a trademark application was filed for VERTEX GENETIC THERAPIES with the United States Patent and Trademark Office. The USPTO has given the VERTEX GENETIC THERAPIES trademark a serial number of 88611633. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, June 7, 2020. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VERTEX GENETIC THERAPIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
General Information
| Serial Number | 88611633 |
| Word Mark | VERTEX GENETIC THERAPIES |
| Filing Date | Tuesday, September 10, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Sunday, June 7, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of a geometric shape bisected into two parts, the left part containing the word VERTEX between sections of a triangle, the right part containing the words GENETIC over THERAPIES over a background of short lines. |
| Goods and Services | house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy |
| Goods and Services | medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 19, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 19, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vertex Pharmaceuticals Incorporated |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Monday, June 8, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Sunday, June 7, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, February 10, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 20, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, November 14, 2019 | ASSIGNED TO EXAMINER |
| Friday, September 20, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, September 13, 2019 | NEW APPLICATION ENTERED IN TRAM |
